CTOs on the Move

Integrated Viral Protection

www.ivpair.com

 
World-Leading Biodefense Indoor Air Protection Systemâ„¢ Scientifically proven to destroy COVID-19 (99.999%) and Anthrax spores (99.98%) instantaneously in a single pass. Learn More Scientifically proven to Kill Sars-CoV-2, the virus that causes COVID-19...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ivpair.com
  • 7670, Woodway Drive
    Houston, TX USA 77063
  • Phone: 800.713.4872

Executives

Name Title Contact Details

Similar Companies

Novel Laboratories

Novel Laboratories is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novasite Pharmaceutical

Novasite Pharmaceutical is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dsr Pharmaceuticals

Dsr Pharmaceuticals is a Playa Del Rey, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 US jurisdictions and the EU. Columbia Care is one of the original providers of medical cannabis in the United States, and continues to deliver an industry-leading, patient-centered medicinal cannabis operation that has quickly expanded into the adult use market as a premier operator. The company currently offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Amber and Platinum Label CBD. With more than four million sales transactions since its inception in 2012, Columbia Care is known for setting the standard for compassion, professionalism, quality, care, and innovation in the rapidly expanding cannabis industry. Must be 21+ to follow.

POZEN

POZEN Inc. is a specialty pharmaceutical company that to date has historically focused on developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products. Funded by these milestones/royalty streams, POZEN has created a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.